Zalutumumab plus best supportive care versus best supportive care alone in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck after failure of platinum-based chemotherapy: an open-label, randomised phase 3 trial

Publication | Closed Access

DOI

240

Citations

References

2011

Year

Jean-Pascal Machiels, Somasundaram Subramanian, Ágnes Ruzsa, Gábor Répássy, Igor Lifirenko, Annika Flygare, Per Soelberg Sørensen, Tina Nielsen, Steen Lisby, Paul M. Clément

The Lancet Oncology

Neoadjuvant TherapyMedicineRandomised Phase 3Cancer ManagementClinical TrialsHead And Neck CancerCancer TreatmentNeck OncologyOncologyRadiation OncologyPlatinum-based ChemotherapyHealth Sciences